Abbott Labs delivered a second-quarter earnings beat on Thursday, but the company's ongoing litigation over its baby formula — plus softer guidance for the current quarter — is dragging down shares. We view the pullback as an opportunity. Revenue for the three months ended June 30 rose 4% year over year to $10.38 billion, slightly ahead of expectations, according to LSEG. On an organic basis, sales were up 9.3% versus the year-ago period , also ahead of expectations.
Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES 2022 at The Venetian Las Vegas on January 6, 2022 in Las Vegas, Nevada.delivered a second-quarter earnings beat on Thursday, but the company's ongoing litigation over its baby formula — plus softer guidance for the current quarter — is dragging down shares. We view the pullback as an opportunity.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Fonte: CNBC - 🏆 12. / 72 Consulte Mais informação »
Fonte: AP - 🏆 728. / 51 Consulte Mais informação »
Fonte: wjxt4 - 🏆 246. / 63 Consulte Mais informação »
Fonte: ksatnews - 🏆 442. / 53 Consulte Mais informação »